|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,079,680 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,387 |
|
|
Total
Value |
$65,018,530 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 17 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-12 |
4 |
D |
$67.68 |
$600,525 |
D/D |
(8,873) |
102,165 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-12 |
4/A |
D |
$67.68 |
$591,659 |
D/D |
(8,742) |
102,165 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-05-08 |
4 |
D |
$56.78 |
$311,098 |
D/D |
(5,479) |
189,756 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-05-12 |
4 |
D |
$59.30 |
$270,823 |
D/D |
(4,567) |
185,189 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-05-15 |
4 |
D |
$57.44 |
$283,294 |
D/D |
(4,932) |
180,257 |
0 |
- |
|
ITMN |
InterMune Inc |
Director |
|
2014-09-29 |
4 |
D |
$74.00 |
$630,850 |
D/D |
(8,525) |
1,200 |
0 |
- |
|
ITMN |
InterMune Inc |
Director |
|
2014-09-29 |
4 |
D |
$74.00 |
$88,800 |
D/D |
(1,200) |
0 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-05-08 |
4 |
D |
$121.66 |
$666,575 |
D/D |
(5,479) |
243,175 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-05-12 |
4 |
D |
$121.09 |
$284,440 |
D/D |
(2,349) |
240,826 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-05-15 |
4 |
D |
$122.78 |
$605,551 |
D/D |
(4,932) |
235,894 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-06-04 |
4 |
D |
$120.46 |
$799,854 |
D/D |
(6,640) |
229,254 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-02-29 |
4 |
D |
$81.87 |
$15,799,436 |
D/D |
(192,982) |
350,500 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-03-03 |
4 |
D |
$89.57 |
$805,145 |
D/D |
(8,989) |
331,511 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-05-06 |
4 |
D |
$80.80 |
$442,703 |
D/D |
(5,479) |
390,156 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-05-13 |
4 |
D |
$82.71 |
$407,926 |
D/D |
(4,932) |
385,224 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-06-03 |
4 |
D |
$90.00 |
$597,600 |
D/D |
(6,640) |
378,584 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-03 |
4 |
D |
$93.95 |
$844,517 |
D/D |
(8,989) |
206,364 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-15 |
4 |
D |
$92.50 |
$1,451,325 |
D/D |
(15,690) |
190,674 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-15 |
4 |
D |
$91.50 |
$451,278 |
D/D |
(4,932) |
233,564 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-06-02 |
4 |
D |
$90.72 |
$602,381 |
D/D |
(6,640) |
226,924 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-02 |
4 |
D |
$79.86 |
$682,164 |
D/D |
(8,542) |
264,674 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-15 |
4 |
D |
$83.57 |
$1,245,862 |
D/D |
(14,908) |
249,766 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-22 |
4 |
D |
$81.36 |
$1,063,782 |
D/D |
(13,075) |
284,031 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-22 |
4/A |
D |
$81.36 |
$1,068,013 |
D/D |
(13,127) |
283,979 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-06-04 |
4 |
D |
$92.07 |
$580,962 |
D/D |
(6,310) |
284,290 |
0 |
- |
|
852 Records found
|
|
Page 17 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|